Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 5/2019

Open Access 01-10-2019 | Ulcerative Colitis | Case Report

Papaverine adjuvant therapy for microcirculatory disturbance in severe ulcerative colitis complicated with CMV infection: a case report

Authors: Yu Tian, Yue Zheng, Jinpei Dong, Jixin Zhang, Huahong Wang

Published in: Clinical Journal of Gastroenterology | Issue 5/2019

Login to get access

Abstract

Ulcerative colitis has hypercoagulable state and high risk of thrombosis; so mucosal disturbance of microcirculation may be mediate and amplify the inflammation of ulcerative colitis. A 56-year-old female patient was admitted in hospital for discontinuously mucous bloody stool for more than 1 year. Ulcerative colitis was determined after colonoscopy and pathologic examination. Mesalazine was effective during the year, but her symptoms recurred three times due to her bad compliance. One month before admission, the patient had severe recurrence after mesalazine withdrawal. At this time, the result of quantitative fluorescence PCR of colonic histic CMV-DNA was 1.6 × 104 copies/mL positive, CMV colitis was accompanied. After 4 weeks of ganciclovir and 6 weeks of mesalazine usage and nutrition support, the symptoms of diarrhea and abdominal cramp did not improve; stool frequency was more than twenty times a day. Probe-based confocal laser endomicroscopy revealed local microcirculation disturbance. Papaverine 90-mg slow drip for at least 10 h a day was added. The symptoms dramatically disappeared after 3 days of papaverine treatment. The patient had yellow mushy stool 2–3 times a day. Pathological findings showed diffuse submucosal hemorrhage and transparent thrombosis in capillaries. Treatment of microcirculatory disturbance in severe UC is a promising adjuvant therapy. Confocal laser endomicroscopy may be an effective method for microcirculation judgment.
Literature
1.
go back to reference Bollen L, Vande Casteele N, Ballet V, et al. Thromboembolism as an important complication of inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2016;28:1–7.CrossRef Bollen L, Vande Casteele N, Ballet V, et al. Thromboembolism as an important complication of inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2016;28:1–7.CrossRef
2.
go back to reference He G, Ouyang Q, Chen D, et al. The microvascular thrombi of colonic tissue in ulcerative colitis. Dig Dis Sci. 2007;52:2236–40.CrossRef He G, Ouyang Q, Chen D, et al. The microvascular thrombi of colonic tissue in ulcerative colitis. Dig Dis Sci. 2007;52:2236–40.CrossRef
3.
go back to reference Stadnicki A. Involvement of coagulation and hemostasis in inflammatory bowel diseases. Curr Vasc Pharmacol. 2012;10:659–69.CrossRef Stadnicki A. Involvement of coagulation and hemostasis in inflammatory bowel diseases. Curr Vasc Pharmacol. 2012;10:659–69.CrossRef
4.
go back to reference Yazeji T, Moulari B, Beduneau A, et al. Nanoparticle-based delivery enhances anti-inflammatory effect of low molecular weight heparin in experimental ulcerative colitis. Drug Deliv. 2017;24:811–7.CrossRef Yazeji T, Moulari B, Beduneau A, et al. Nanoparticle-based delivery enhances anti-inflammatory effect of low molecular weight heparin in experimental ulcerative colitis. Drug Deliv. 2017;24:811–7.CrossRef
5.
go back to reference Harris NR, Specian RD, Carter PR, et al. Contrasting effects of pseudoephedrine and papaverine in dextran sodium sulfate-induced colitis. Inflamm Bowel Dis. 2008;14:318–23.CrossRef Harris NR, Specian RD, Carter PR, et al. Contrasting effects of pseudoephedrine and papaverine in dextran sodium sulfate-induced colitis. Inflamm Bowel Dis. 2008;14:318–23.CrossRef
6.
go back to reference Saijo H, Tatsumi N, Arihiro S, et al. Microangiopathy triggers, and inducible nitric oxide synthase exacerbates dextran sulfate sodium-induced colitis. Lab Investig. 2015;95:728–48.CrossRef Saijo H, Tatsumi N, Arihiro S, et al. Microangiopathy triggers, and inducible nitric oxide synthase exacerbates dextran sulfate sodium-induced colitis. Lab Investig. 2015;95:728–48.CrossRef
7.
go back to reference Koutroubakis IE, Tsiolakidou G, Karmiris K, et al. Role of angiogenesis in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:515–23.CrossRef Koutroubakis IE, Tsiolakidou G, Karmiris K, et al. Role of angiogenesis in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:515–23.CrossRef
8.
go back to reference D’Alessio S, Tacconi C, Fiocchi C, et al. Advances in therapeutic interventions targeting the vascular and lymphatic endothelium in inflammatory bowel disease. Curr Opin Gastroenterol. 2013;29:608–13.CrossRef D’Alessio S, Tacconi C, Fiocchi C, et al. Advances in therapeutic interventions targeting the vascular and lymphatic endothelium in inflammatory bowel disease. Curr Opin Gastroenterol. 2013;29:608–13.CrossRef
9.
go back to reference Sherid M, Samo S, Sulaiman S, et al. Comparison of ischemic colitis in the young and the elderly. WMJ. 2016;115:196–202.PubMed Sherid M, Samo S, Sulaiman S, et al. Comparison of ischemic colitis in the young and the elderly. WMJ. 2016;115:196–202.PubMed
10.
go back to reference Maione F, Giglio MC, Luglio G, et al. Confocal laser endomicroscopy in ulcerative colitis: beyond endoscopic assessment of disease activity. Tech Coloproctol. 2017;21:531–40.CrossRef Maione F, Giglio MC, Luglio G, et al. Confocal laser endomicroscopy in ulcerative colitis: beyond endoscopic assessment of disease activity. Tech Coloproctol. 2017;21:531–40.CrossRef
11.
go back to reference Rasmussen DN, Karstensen JG, Riis LB, et al. Confocal laser endomicroscopy in inflammatory bowel disease–a systematic review. J Crohns Colitis. 2015;9:1152–9.CrossRef Rasmussen DN, Karstensen JG, Riis LB, et al. Confocal laser endomicroscopy in inflammatory bowel disease–a systematic review. J Crohns Colitis. 2015;9:1152–9.CrossRef
12.
go back to reference Nakai Y, Isayama H, Shinoura S, et al. Confocal laser endomicroscopy in gastrointestinal and pancreatobiliary diseases. Dig Endosc. 2014;26(Suppl 1):86–94.CrossRef Nakai Y, Isayama H, Shinoura S, et al. Confocal laser endomicroscopy in gastrointestinal and pancreatobiliary diseases. Dig Endosc. 2014;26(Suppl 1):86–94.CrossRef
13.
go back to reference Gheonea DI, Saftoiu A, Ciurea T, et al. Confocal laser endomicroscopy of the colon. J Gastrointestin Liver Dis. 2010;19:207–11.PubMed Gheonea DI, Saftoiu A, Ciurea T, et al. Confocal laser endomicroscopy of the colon. J Gastrointestin Liver Dis. 2010;19:207–11.PubMed
14.
go back to reference Liu JJ, Wong K, Thiesen AL, et al. Increased epithelial gaps in the small intestines of patients with inflammatory bowel disease: density matters. Gastrointest Endosc. 2011;73:1174–80.CrossRef Liu JJ, Wong K, Thiesen AL, et al. Increased epithelial gaps in the small intestines of patients with inflammatory bowel disease: density matters. Gastrointest Endosc. 2011;73:1174–80.CrossRef
15.
go back to reference Hundorfean G, Chiriac MT, Mihai S, et al. Development and validation of a confocal laser endomicroscopy-based score for in vivo assessment of mucosal healing in ulcerative colitis patients. Inflamm Bowel Dis. 2017;24:35–44.CrossRef Hundorfean G, Chiriac MT, Mihai S, et al. Development and validation of a confocal laser endomicroscopy-based score for in vivo assessment of mucosal healing in ulcerative colitis patients. Inflamm Bowel Dis. 2017;24:35–44.CrossRef
16.
go back to reference Deban L, Correale C, Vetrano S, et al. Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades. Am J Pathol. 2008;172:1457–66.CrossRef Deban L, Correale C, Vetrano S, et al. Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades. Am J Pathol. 2008;172:1457–66.CrossRef
17.
go back to reference Harris NR, Carter PR, Watts MN, et al. Relationship among circulating leukocytes, platelets, and microvascularresponses during induction of chronic colitis. Pathophysiology. 2011;18:305–11.CrossRef Harris NR, Carter PR, Watts MN, et al. Relationship among circulating leukocytes, platelets, and microvascularresponses during induction of chronic colitis. Pathophysiology. 2011;18:305–11.CrossRef
18.
go back to reference Sankey EA, Dhillon AP, Anthony A, et al. Early mucosal changes in Crohn’s disease. Gut. 1993;34:375–81.CrossRef Sankey EA, Dhillon AP, Anthony A, et al. Early mucosal changes in Crohn’s disease. Gut. 1993;34:375–81.CrossRef
19.
go back to reference Kredel LI, Mundt P, van Riesen L, et al. Accuracy of diagnostic tests and a new algorithm for diagnosing cytomegalovirus colitis in inflammatory bowel diseases: a diagnostic study. Int J Colorectal Dis. 2019;34:229–37.CrossRef Kredel LI, Mundt P, van Riesen L, et al. Accuracy of diagnostic tests and a new algorithm for diagnosing cytomegalovirus colitis in inflammatory bowel diseases: a diagnostic study. Int J Colorectal Dis. 2019;34:229–37.CrossRef
20.
go back to reference Kahl M, Siegel-Axel D, Stenglein S, et al. Efficient lytic infection of human arterial endothelial cells by human cytomegalovirus strains. J Virol. 2000;74:7628–35.CrossRef Kahl M, Siegel-Axel D, Stenglein S, et al. Efficient lytic infection of human arterial endothelial cells by human cytomegalovirus strains. J Virol. 2000;74:7628–35.CrossRef
21.
go back to reference Yildiz H, Zech F, Hainaut P. Venous thromboembolism associated with acute cytomegalovirus infection: epidemiology and predisposing conditions. Acta Clin Belg. 2016;71:231–4.CrossRef Yildiz H, Zech F, Hainaut P. Venous thromboembolism associated with acute cytomegalovirus infection: epidemiology and predisposing conditions. Acta Clin Belg. 2016;71:231–4.CrossRef
22.
go back to reference Atzmony L, Halutz O, Avidor B, et al. Incidence of cytomegalovirus-associated thrombosis and its risk factors: a case-control study. Thromb Res. 2010;126:e439–43.CrossRef Atzmony L, Halutz O, Avidor B, et al. Incidence of cytomegalovirus-associated thrombosis and its risk factors: a case-control study. Thromb Res. 2010;126:e439–43.CrossRef
23.
go back to reference Kim SH, Jang S, Sung Y, et al. Use of novel oral anticoagulant to treat pulmonary thromboembolism in patient with ulcerative colitis superinfected cytomegalovirus colitis. Korean J Gastroenterol. 2017;25(70):44–9.CrossRef Kim SH, Jang S, Sung Y, et al. Use of novel oral anticoagulant to treat pulmonary thromboembolism in patient with ulcerative colitis superinfected cytomegalovirus colitis. Korean J Gastroenterol. 2017;25(70):44–9.CrossRef
24.
go back to reference Brahme F, Lindström C. A comparative radiographic and pathological study of intestinal vaso-architecture in Crohn’s disease and in ulcerative colitis. Gut. 1970;11:928–40.CrossRef Brahme F, Lindström C. A comparative radiographic and pathological study of intestinal vaso-architecture in Crohn’s disease and in ulcerative colitis. Gut. 1970;11:928–40.CrossRef
25.
go back to reference Binion DG, Rafiee P. Is inflammatory bowel disease a vascular disease? Targeting angiogenesis improves chronic inflammation in inflammatory bowel disease. Gastroenterology. 2009;136:400–3.CrossRef Binion DG, Rafiee P. Is inflammatory bowel disease a vascular disease? Targeting angiogenesis improves chronic inflammation in inflammatory bowel disease. Gastroenterology. 2009;136:400–3.CrossRef
26.
go back to reference Danese S, Fiorino G, Angelucci E, et al. Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study. World J Gastroenterol. 2010;16:2396–400.CrossRef Danese S, Fiorino G, Angelucci E, et al. Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study. World J Gastroenterol. 2010;16:2396–400.CrossRef
27.
go back to reference Saevik F, Nylund K, Hausken T, et al. Bowel perfusion measured with dynamic contrast-enhanced ultrasound predicts treatment outcome in patients with Crohn’s disease. Inflamm Bowel Dis. 2014;20:2029–37.CrossRef Saevik F, Nylund K, Hausken T, et al. Bowel perfusion measured with dynamic contrast-enhanced ultrasound predicts treatment outcome in patients with Crohn’s disease. Inflamm Bowel Dis. 2014;20:2029–37.CrossRef
28.
go back to reference Karagoz MA, Doluoglu OG, Ünverdi H, et al. The protective effect of papaverine and alprostadil in rat testes after ischemia and reperfusion injury. Int Braz J Urol. 2018;44:617–22.CrossRef Karagoz MA, Doluoglu OG, Ünverdi H, et al. The protective effect of papaverine and alprostadil in rat testes after ischemia and reperfusion injury. Int Braz J Urol. 2018;44:617–22.CrossRef
29.
go back to reference Jablonická V, Ziegler J, Vatehová Z, et al. Inhibition of phospholipases influences the metabolism of wound-induced benzylisoquinoline alkaloids in Papaver somniferum L. J Plant Physiol. 2018;223:1–8.CrossRef Jablonická V, Ziegler J, Vatehová Z, et al. Inhibition of phospholipases influences the metabolism of wound-induced benzylisoquinoline alkaloids in Papaver somniferum L. J Plant Physiol. 2018;223:1–8.CrossRef
30.
go back to reference Koupparis AJ, Jeremy JY, Muzaffar S, et al. Sildenafil inhibits the formation of superoxide and the expression of gp47 NAD[P]H oxidase induced by the thromboxane A2 mimetic, U46619, in corpus cavernosal smooth muscle cells. BJU Int. 2005;96:423–7.CrossRef Koupparis AJ, Jeremy JY, Muzaffar S, et al. Sildenafil inhibits the formation of superoxide and the expression of gp47 NAD[P]H oxidase induced by the thromboxane A2 mimetic, U46619, in corpus cavernosal smooth muscle cells. BJU Int. 2005;96:423–7.CrossRef
31.
go back to reference Toward TJ, Smith N, Broadley KJ. Effect of phosphodiesterase-5 inhibitor, sildenafil (Viagra), in animal models of airways. Am J Respir Crit Care Med. 2004;169:227–34.CrossRef Toward TJ, Smith N, Broadley KJ. Effect of phosphodiesterase-5 inhibitor, sildenafil (Viagra), in animal models of airways. Am J Respir Crit Care Med. 2004;169:227–34.CrossRef
32.
go back to reference Dang Y, Mu Y, Wang K, et al. Papaverine inhibits lipopolysaccharide-induced microglial activation by suppressing NF-κB signaling pathway. Drug Des Devel Ther. 2016;26(10):851–9.CrossRef Dang Y, Mu Y, Wang K, et al. Papaverine inhibits lipopolysaccharide-induced microglial activation by suppressing NF-κB signaling pathway. Drug Des Devel Ther. 2016;26(10):851–9.CrossRef
33.
go back to reference Chande N, MacDonald JK, Wang JJ, et al. Unfractionated or low molecular weight heparin for induction of remission in ulcerative colitis: a Cochrane inflammatory bowel disease and functional bowel disorders systematic review of randomized trials. Inflamm Bowel Dis. 2011;17:1979–86.CrossRef Chande N, MacDonald JK, Wang JJ, et al. Unfractionated or low molecular weight heparin for induction of remission in ulcerative colitis: a Cochrane inflammatory bowel disease and functional bowel disorders systematic review of randomized trials. Inflamm Bowel Dis. 2011;17:1979–86.CrossRef
34.
go back to reference Lean QY, Gueven N, Eri RD, et al. Heparins in ulcerative colitis: proposed mechanisms of action and potential reasons for inconsistent clinical outcomes. Expert Rev Clin Pharmacol. 2015;8:795–811.CrossRef Lean QY, Gueven N, Eri RD, et al. Heparins in ulcerative colitis: proposed mechanisms of action and potential reasons for inconsistent clinical outcomes. Expert Rev Clin Pharmacol. 2015;8:795–811.CrossRef
35.
Metadata
Title
Papaverine adjuvant therapy for microcirculatory disturbance in severe ulcerative colitis complicated with CMV infection: a case report
Authors
Yu Tian
Yue Zheng
Jinpei Dong
Jixin Zhang
Huahong Wang
Publication date
01-10-2019
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 5/2019
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-019-00974-y

Other articles of this Issue 5/2019

Clinical Journal of Gastroenterology 5/2019 Go to the issue